Table: Garna Biosciences -2017 group results

Carna Biosciences

09/02/2018 06:30

Feb 9 (Reuters)-  
          Garna Biosciences Inc  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to        NEXT    
              Dec 31, 2017    Dec 31, 2016    Dec 31, 2018      YEAR      
                 LATEST         YEAR-AGO         COMPANY       COMPANY    
                 RESULTS         RESULTS        FORECAST     H1 FORECAST  
  Sales          657 mln         811 mln          1.19                    
               (-19.0 pct)     (-48.3 pct)     (+81.1 pct)                
  Operating   loss 699 mln    loss 423 mln    loss 679 mln                
  Recurring   loss 711 mln    loss 440 mln    loss 694 mln                
  Net 
  Net         loss 737 mln    loss 289 mln    loss 758 mln                
  EPS        loss 78.53 yen  loss 31.64 yen  loss 79.39 yen               
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
   
  NOTE - Garna Biosciences Inc. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T 
  ((Tokyo Headline News Desk +813 6441 1812))